Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...
December 09 2019 - 4:46PM
Edgar (US Regulatory)
|
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
25
|
|
|
|
|
|
|
|
|
|
NOTIFICATION OF REMOVAL FROM LISTING
AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-37847
MOTIF BIO PLC
The Nasdaq
Stock Market LLC
(Exact name of Issuer as specified in its
charter, and name of Exchange where security is listed and/or registered)
125 Park Avenue
25th Floor
New York, New York 10017
(609) 608-0032
(Address, including zip code, and telephone
number, including area code, of Issuer’s principal executive offices)
American Depositary Shares each representing
20 Ordinary Shares
Ordinary Shares, par value £0.01 per
share not for trading, but only in connection with the registration of the American
Depositary Shares)
Warrants to purchase American Depositary
Shares each representing 20 Ordinary Shares
(Description of class of securities)
Please place an X in the box to designate the rule provision
relied upon to strike the class of securities from listing and registration:
☐
17 CFR 240.12d2-2(a)(1)
☐
17 CFR 240.12d2-2(a)(2)
☐
17 CFR 240.12d2-2(a)(3)
☐
17 CFR 240.12d2-2(a)(4)
☐
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or
withdraw registration on the Exchange.(1)
☒
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c)
governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements of the Securities Exchange Act
of 1934, Motif Bio Plc certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the
Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
December 9, 2019
|
|
By
|
/s/ Graham Lumsden
|
|
Chief Executive Officer
|
Date
|
|
|
Name
|
|
Title
|
(1) Form 25 and attached Notice will be considered compliance
with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Motif Bio (NASDAQ:MTFB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Motif Bio (NASDAQ:MTFB)
Historical Stock Chart
From Apr 2023 to Apr 2024